Literature DB >> 2212145

Treatment of hirsutism with the pure antiandrogen flutamide.

L Cusan1, A Dupont, A Bélanger, R R Tremblay, G Manhes, F Labrie.   

Abstract

The effectiveness of the antiandrogen flutamide in combination with an oral contraceptive was studied in 20 patients with moderate to severe hirsutism. Eight patients had no previous therapy, whereas 12 had failed to respond to oral contraceptives, spironolactone, or dexamethasone therapy. Treatment with the antiandrogen flutamide (250 mg twice daily) and an oral contraceptive (Ortho 1/35) resulted in a particularly rapid and marked decrease in the total hirsutism score, which reached the normal range at 7 months. Seborrhea, acne, and hair loss score were also rapidly corrected. Treatment was associated with a decrease in plasma luteinizing hormone, progesterone, and estradiol levels. Plasma sex hormone-binding globulin levels were initially low in 18 to 20 patients but increased significantly during therapy. No clinically significant side effects were observed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2212145     DOI: 10.1016/0190-9622(90)70241-9

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  5 in total

Review 1.  How actual is the treatment with antiandrogen alone in patients with polycystic ovary syndrome?

Authors:  E Diamanti-Kandarakis
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

Review 2.  Hirsutism: evaluation and management.

Authors:  R E Watson; R Bouknight; P C Alguire
Journal:  J Gen Intern Med       Date:  1995-05       Impact factor: 5.128

Review 3.  A risk-benefit assessment of pharmacological therapies for hirsutism.

Authors:  E Carmina
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 4.  A practical guide to the diagnosis and management of amenorrhoea.

Authors:  P G Crosignani; W Vegetti
Journal:  Drugs       Date:  1996-11       Impact factor: 9.546

Review 5.  [Toxic hepatitis and liver failure under therapy with flutamide].

Authors:  C Lübbert; M Wiese; R Haupt; B R Ruf
Journal:  Internist (Berl)       Date:  2004-03       Impact factor: 0.743

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.